Positron emission tomography for staging of pediatric sarcoma patients: Results of a prospective multicenter trial

Journal of Clinical Oncology

Volumn 25, Issue 34, 2007, Pages 5435-5441

  Völker, Thomas ^a   Denecke, Timm ^a   Steffen, Ingo ^a   Misch, Daniel ^a   Schönberger, Stefan ^a   Plotkin, Michail ^a   Ruf, Juri ^a   Furth, Christian ^a   Stöver, Brigitte ^a   Hautzel, Hubertus ^a   Henze, Günter ^a   Amthauer, Holger ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT; TECHNETIUM PHOSPHONATE TC 99M; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; CANCER DIAGNOSIS; CANCER STAGING; CHILD; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DRUG UPTAKE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMAGING SYSTEM; INTERMETHOD COMPARISON; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RHABDOMYOSARCOMA; SENSITIVITY AND SPECIFICITY; TUMOR BIOPSY; ULTRASOUND; WHOLE BODY PET;

ADOLESCENT; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INFANT; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; NEOPLASM STAGING; OSTEOSARCOMA; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; RHABDOMYOSARCOMA; SARCOMA; SARCOMA, EWING'S; TOMOGRAPHY, X-RAY COMPUTED;

EID: 36849068327     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.12.2473     Document Type: Article

References (34)

1. Bielack SS, Kempf-Bielack B, Delling G, et al: Prognostic factors in high-grade osteosarcoma of the extremities or trunk: An analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 20:776-790, 2002
2. Cangir A, Vietti TJ, Gehan EA, et al: Ewing's sarcoma metastatic at diagnosis: Results and comparisons of two intergroup Ewing's sarcoma studies. Cancer 66:887-893, 1990
3. Paulussen M, Ahrens S, Burdach S, et al: Primary metastatic (stage IV) Ewing tumor: Survival analysis of 171 patients from the EICESS studies - European Intergroup Cooperative Ewing Sarcoma Studies. Ann Oncol 9:275-281, 1998
4. Koscielniak E, Harms D, Henze G, et al: Results of treatment for soft tissue sarcoma in childhood and adolescence: A final report of the German Cooperative Soft Tissue Sarcoma Study CWS-86. J Clin Oncol 17:3706-3719, 1999
5. Winkler K, Beron G, Delling G, et al: Neoadjuvant chemotherapy of osteosarcoma: Results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response. J Clin Oncol 6:329-337, 1988
6. Fuchs N, Bielack SS, Epler D, et al: Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs. Ann Oncol 9:893-899, 1998
7. Koscielniak E, Jurgens H, Winkler K, et al: Treatment of soft tissue sarcoma in childhood and adolescence: A report of the German Cooperative Soft Tissue Sarcoma Study. Cancer 70:2557-2567, 1992
8. Paulussen M, Frohlich B, Jurgens H: Ewing tumour: Incidence, prognosis and treatment options. Paediatr Drugs 3:899-913, 2001
9. Koscielniak E, Morgan M, Treuner J: Soft tissue sarcoma in children: Prognosis and management. Paediatr Drugs 4:21-28, 2002
10. Winkler K, Bielack SS, Delling G, et al: Treatment of osteosarcoma: Experience of the Cooperative Osteosarcoma Study Group (COSS). Cancer Treat Res 62:269-277, 1993
11. Walterhouse DO, Lyden ER, Breitfeld PP, et al: Efficacy of topotecan and cyclophosphamide given in a phase II window trial in children with newly diagnosed metastatic rhabdomyosarcoma: A Children's Oncology Group study. J Clin Oncol 22:1398-1403, 2004
12. Czyzewski EA, Goldman S, Mundt AJ, et al: Radiation therapy for consolidation of metastatic or recurrent sarcomas in children treated with intensive chemotherapy and stem cell rescue: A feasibility study. Int J Radiat Oncol Biol Phys 44:569-577, 1999
13. Krasin MJ, Rodriguez-Galindo C, Billups CA, et al: Definitive irradiation in multidisciplinary management of localized Ewing sarcoma family of tumors in pediatric patients: Outcome and prognostic factors. Int J Radiat Oncol Biol Phys 60:830-838, 2004
14. Wharam MD, Meza J, Anderson J, et al: Failure pattern and factors predictive of local failure in rhabdomyosarcoma: A report of group III patients on the third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 22:1902-1908, 2004
15. Flamant F, Rodary C, Rey A, et al: Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence: Results of the second study of the International Society of Paediatric Oncology - MMT84. Eur J Cancer 34:1050-1062, 1998
16. Bacci G, Ferrari S, Longhi A, et al: Pattern of relapse in patients with osteosarcoma of the extremities treated with neoadjuvant chemotherapy. Eur J Cancer 37:32-38, 2001
17. Weeden S, Grimer RJ, Cannon SR, et al: The effect of local recurrence on survival in resected osteosarcoma. Eur J Cancer 37:39-46, 2001
18. Torabi M, Aquino SL, Harisinghani MG: Current concepts in lymph node imaging. J Nucl Med 45:1509-1518, 2004
19. Golder WA: Lymph node diagnosis in oncologic imaging: A dilemma still waiting to be solved. Onkologie 27:194-199, 2004
20. Franzius C, Sciuk J, Daldrup-Link HE, et al: FDG-PET for detection of osseous metastases from malignant primary bone tumours: Comparison with bone scintigraphy. Eur J Nucl Med 27:1305-1311, 2000
21. Gyorke T, Zajic T, Lange A, et al: Impact of FDG PET for staging of Ewing sarcomas and primitive neuroectodermal tumours. Nucl Med Commun 27:17-24, 2006
22. Schuetze SM: Utility of positron emission tomography in sarcomas. Curr Opin Oncol 18:369-373, 2006
23. Schuetze SM, Rubin BP, Vernon C, et al: Use of positron emission tomography in localized extremity soft tissue sarcoma treated with neoadjuvant chemotherapy. Cancer 103:339-348, 2005
24. Lucas JD, O'Doherty MJ, Cronin BF, et al: Prospective evaluation of soft tissue masses and sarcomas using fluorodeoxyglucose positron emission tomography. Br J Surg 86:550-556, 1999
25. Franzius C, Daldrup-Link HE, Sciuk J, et al: FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: Comparison with spiral CT. Ann Oncol 12:479-486, 2001
26. Klem ML, Grewal RK, Wexler LH, et al: PET for staging in rhabdomyosarcoma: An evaluation of PET as an adjunct to current staging tools. J Pediatr Hematol Oncol 29:9-14, 2007
27. Kneisl JS, Patt JC, Johnson JC, et al: Is PET useful in detecting occult nonpulmonary metastases in pediatric bone sarcomas? Clin Orthop Relat Res 450:101-104, 2006
28. Furth C, Denecke T, Steffen I, et al: Correlative imaging strategies implementing CT, MRI, and PET for staging of childhood Hodgkin disease. J Pediatr Hematol Oncol 28:501-512, 2006
29. Bennet BM: On comparisons of sensitivity, specificity, and predictive value of a number of diagnostic procedures. Biometrics 28:793-800, 1972
30. Franzius C, Bielack S, Flege S, et al: Prognostic significance of (18)F-FDG and (99m)Tc-methylene diphosphonate uptake in primary osteosarcoma. J Nucl Med 43:1012-1017, 2002
31. Hawkins DS, Schuetze SM, Butrynski JE, et al: [18F]Fluorodeoxyglucose positron emission tomography predicts outcome for Ewing sarcoma family of tumors. J Clin Oncol 23:8828-8834, 2005
32. Reddick RL, Michelitch HJ, Levine AM, et al: Osteogenic sarcoma: A study of the ultrastructure. Cancer 45:64-71, 1980
33. Furth C, Amthauer H, Denecke T, et al: Impact of whole-body MRI and FDG-PET on staging and assessment of therapy response in a patient with Ewing sarcoma. Pediatr Blood Cancer 47:607-611, 2006
34. Rodeberg D, Paidas C: Childhood rhabdomyosarcoma. Semin Pediatr Surg 15:57-62, 2006